This observational, retrospective study demonstrated the prevalence and prognostic value of PD-L1 and PD-L2 protein expression and their coexpression in ES-SCLC tumor specimens collected from Danish patients receiving standard of care before the introduction of immunotherapy. The gene discussed is PDCD1LG2; the disease is neoplasm.